Across
- 2. A drop in heartrate below 60 beats per minute should alert the nurse to hold dosing for this class of antihypertensive and not doing so with a heart rate below 60 may result in an adverse effect of heart failure.
- 6. This class of antihypertensive is often used as “first-line therapy” in African American individuals with hypertension based on evidence outlined in the JNC 8 guidelines.
- 11. With this anticoagulant, monitoring PT/INR is essential and it is important to avoid drastic changes in the amount of leafy green veggies consumed; other than monitoring therapeutic range using coagulation labs, patients should also be taught to monitor for bruising, bleeding gums, bloody / abnormally dark / tarry stools.
- 13. This class of antihypertensive should be discontinued if a cough develops, may cause an increase in potassium levels, and targets the renin angiotensin aldosterone cascade in the kidneys to prevent water and sodium retention to decrease blood pressure.
- 15. This type of hypotension is worsened by position changes, and should be monitored for in patients who are newly prescribed any class of antihypertensive medications.
- 16. The normal range for this therapeutic drug value is 0.5-2mcg/ml.
- 17. No monitoring of coagulation studies for therapeutic range is required for this injectable (SQ) low molecular weight heparin.
Down
- 1. This medication is classified as a nitrate, should be stored in a dark container, and may be taken up to three doses sublingually to relive chest pain.
- 3. The normal range for this lab value is 3.5-5.2 mcg/ml and a drop in this lab value will potentiate (increase)digoxin toxicity.
- 4. This component of the vital signs is monitored with beta-blockers and inotropic agents, which are held with a value under 60.
- 5. In hospitalized patients requiring anticoagulation for an existing thrombosis (clot), this medication will be continued intravenously until therapeutic levels of oral Warfarin (Coumadin) are reached. This medication is administered subcutaneously (SQ) based on patient weight rather than PTT values when used prophylactically for thrombus prevention.
- 7. These receptors of the adrenergic system targeted to reduce blood pressure, are associated with male reproductive function, and impotence may result when they are antagonized (blocked).
- 8. This abnormality of the cardiovascular system is often referred to as a “silent disease” due to the damaging effects to the renal system that often occur prior to adequately managing the disease.
- 9. This class of medication is given to patients experiencing active stroke or myocardial infarction (heart attack), but can only be given if a specific criteria is met which includes onset of symptoms not to exceed 4 hours ago.
- 10. This lab value is monitored to maintain therapeutic levels of IV Heparin and the therapeutic range is achieved with a value between 60-80 seconds.
- 12. This lab value is used together with the PT to monitor therapeutic range of warfarin (Coumadin), the therapeutic range of this lab value indicating warfarin is at an effective level in the body is between 2-3.
- 14. This class of diuretics would be an expected medication ordered for a patient with cerebral edema (swelling in the brain)